Pages that link to "Q72006850"
Jump to navigation
Jump to search
The following pages link to Ten-year incidence of visual loss in a diabetic population (Q72006850):
Displaying 50 items.
- Anti-vascular endothelial growth factor for proliferative diabetic retinopathy (Q24187858) (← links)
- Anti-vascular endothelial growth factor for proliferative diabetic retinopathy (Q24236189) (← links)
- Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology (Q26744760) (← links)
- Update on genetics and diabetic retinopathy (Q26773225) (← links)
- Approaches to prevention of cardiovascular complications and events in diabetes mellitus (Q28209964) (← links)
- Macular circulation in patients with diabetes mellitus with and without arterial hypertension (Q30968561) (← links)
- Intravitreal triamcinolone for refractory diabetic macular edema (Q31050662) (← links)
- The National Diabetic Retinopathy Laser Treatment Audit. II. Proliferative retinopathy (Q32061844) (← links)
- Surgical treatment of diabetic retinopathy and maculopathy (Q33209796) (← links)
- In diabetic retinopathy, foveal thickness of 300 mum seems to correlate with functionally significant loss of vision (Q33270027) (← links)
- Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema (Q33325652) (← links)
- Diabetic retinopathy: an update (Q33328784) (← links)
- A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema (Q33355710) (← links)
- A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features (Q33359510) (← links)
- Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema (Q33416368) (← links)
- Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (Q33484030) (← links)
- Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction (Q33542927) (← links)
- Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema (Q33567438) (← links)
- The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy (Q33624444) (← links)
- Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study. (Q33812061) (← links)
- Optical Coherence Tomography in the Diagnosis and Management of Diabetic Macular Edema: Time-Domain Versus Spectral-Domain (Q33971687) (← links)
- Efficacy of intravitreal anti-vascular endothelial growth factor or steroid injection in diabetic macular edema according to fluid turbidity in optical coherence tomography (Q33996047) (← links)
- Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability (Q34088274) (← links)
- In diabetic eyes, multifocal ERG reflects differences in function between the nasal part and the temporal part of the macula (Q34158054) (← links)
- Evaluation of a Novel, Non Contact, Automated Focal Laser with Integrated (NAVILAS) Fluorescein Angiography for Diabetic Macular Edema. (Q34161981) (← links)
- Diabetic macular edema: therapeutic options (Q34185374) (← links)
- Epidemiology of diabetic retinopathy and macular oedema: a systematic review (Q34330907) (← links)
- Correlation Between the Findings of Optical Coherent Retinal Tomography (OCT), Stereo Biomicroscopic Images from Fundus of an Eye and Values from Visual Acuity of Diabetic Macular Edema (Q34436760) (← links)
- HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin (Q34775400) (← links)
- Molecular genetics of microvascular disease in diabetic retinopathy (Q35118702) (← links)
- Ocular pulse amplitude in diabetes mellitus (Q35312551) (← links)
- Incidence of blindness due to diabetic eye disease in Fife 1990-9. (Q35318774) (← links)
- The North Jutland County Diabetic Retinopathy Study: population characteristics. (Q35762681) (← links)
- High Prevalence of Diabetic Retinopathy in Diabetic Patients Concomitant with Metabolic Syndrome (Q35888609) (← links)
- Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States (Q36078537) (← links)
- Intravitreal Conbercept Injection with and without Grid Laser Photocoagulation in the Treatment of Diffuse Diabetic Macular Edema in Real-Life Clinical Practice (Q36173627) (← links)
- Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema. (Q36391018) (← links)
- New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy (Q36410647) (← links)
- Role of hypoxia-inducible factor-2alpha in endothelial development and hematopoiesis (Q36999072) (← links)
- Genetics in diabetic retinopathy: current concepts and new insights (Q37148800) (← links)
- Non-traditional systemic treatments for diabetic retinopathy: an evidence-based review (Q37204025) (← links)
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes (Q37218851) (← links)
- The possible impact of uveitis in blindness: a literature survey (Q37323541) (← links)
- Body mass index: a risk factor for retinopathy in type 2 diabetic patients (Q37368103) (← links)
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes (Q37387208) (← links)
- Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes (Q37398317) (← links)
- Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY). (Q37699938) (← links)
- Meta-analysis and review on the effect of bevacizumab in diabetic macular edema (Q37776162) (← links)
- Does familial clustering of risk factors for long-term diabetic complications leave any place for genes that act independently? (Q38021404) (← links)
- Paired responses to intravitreal bevacizumab in diabetic macular edema: predictors of response in the fellow eye. (Q38123086) (← links)